Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Oncoimmunology|May 5, 2020
Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodiesJacobo Rogado, Nuria Romero-Laorden, José Miguel Sanchez-Torres, et al.
BMJ Open Sport & Exercise Medicine|November 29, 2023
Response to physical activity of females with multiple sclerosis throughout the menstrual cycle: a protocol for a randomised crossover trial (EMMA Project)Jacobo Á Rubio-Arias, Domingo J Ramos-Campo, Nuria Romero-Parra, et al.
International Journal of Environmental Research and Public Health|February 9, 2021
Methodological Approach of the Iron and Muscular Damage: Female Metabolism and Menstrual Cycle during Exercise Project (IronFEMME Study)Ana B Peinado, Victor M Alfaro-Magallanes, Nuria Romero-Parra, et al.
Cancers|June 2, 2021
Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) PatientsRebeca Lozano, David Lorente, Isabel M Aragon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2016
Targeted Sequencing Reveals Low-Frequency Variants in <i>EPHA</i> Genes as Markers of Paclitaxel-Induced Peripheral NeuropathyMaría Apellániz-Ruiz, Héctor Tejero, Lucía Inglada-Pérez, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2019
Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancerVincenza Conteduca, Elena Castro, Daniel Wetterskog, et al.
British Journal of Cancer|August 23, 2018
Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study)Nuria Romero-Laorden, Rebeca Lozano, Anuradha Jayaram, et al.
Nature Communications|September 26, 2015
A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like familiesOriol Calvete, Paula Martinez, Pablo Garcia-Pavia, et al.
European Urology Oncology|July 17, 2019
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative AnalysisPasquale Rescigno, David Dolling, Vincenza Conteduca, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2021
Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancerRebeca Lozano, Daniela C Salles, Shahneen Sandhu, et al.
Pageof 12